NCT06184152View on ClinicalTrials.gov

CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules

NARecruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

November 28, 2023

Primary Completion Date

November 28, 2028

Study Completion Date

November 28, 2028

Conditions
HCCHepatocellular Carcinoma
Interventions
DIAGNOSTIC_TEST

CEUS imaging

Contrast-enhanced ultrasound (CEUS)

DIAGNOSTIC_TEST

aMRI imaging

contrast enhanced abbreviated MRI (AMRI)

Trial Locations (2)

48109

RECRUITING

University of Michigan, Ann Arbor

75390

RECRUITING

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

University of Michigan

OTHER

lead

University of Texas Southwestern Medical Center

OTHER